The prevalence of type 2 diabetes (T2D) is rising rapidly worldwide. In September 2012, the World Health Organization reported a global prevalence exceeding 300 million people, predicting a further 60–70% increase by the year 2030 (1). One of the largest absolute increases is expected to occur in India, with the International Diabetes Federation estimating that India alone will have 100 million people with diabetes by 2030 (2). About 90% of these will have T2D.